Form 8-K - Current report:
SEC Accession No. 0001144204-15-064112
Filing Date
2015-11-10
Accepted
2015-11-10 16:04:56
Documents
2
Period of Report
2015-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v424245_8k.htm 8-K 14488
2 EXHIBIT 99.1 v424245_ex99-1.htm EX-99.1 82341
  Complete submission text file 0001144204-15-064112.txt   98183
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Filer) CIK: 0001311596 (see all company filings)

EIN.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35953 | Film No.: 151218898
SIC: 2834 Pharmaceutical Preparations